Logotype for Healwell AI Inc

Healwell AI (AIDX) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Healwell AI Inc

Q4 2024 earnings summary

2 Jul, 2026

Executive summary

  • Achieved record Q4 2024 revenue of CAD 15.2 million (up 692% year-over-year) and gross profit of CAD 7 million (up 1,179% year-over-year), driven by acquisitions and AI commercialization.

  • Full-year 2024 revenue reached CAD 39 million, with four strategic acquisitions completed and the transformative Orion Health acquisition announced, expected to close April 1, 2025.

  • Orion Health acquisition will add over CAD 100 million in annual revenue and make the company EBITDA-positive, expanding global reach and SaaS recurring revenue.

  • Signed 30 master service agreements with life sciences partners, including seven of the top 10 global pharma companies.

  • Growth driven by acquisitions of Intrahealth Solutions, VeroSource Solutions, Bio Pharma Services, Mutuo Health Solutions, and expansion in life sciences partnerships.

Financial highlights

  • Fiscal 2024 revenue from continuing operations was CAD 39 million, up from CAD 7.3 million in 2023.

  • Gross profit for 2024 was CAD 17 million (44% margin), up from CAD 1.2 million (17% margin) in 2023.

  • Q4 2024 revenue was CAD 15.2 million (up 692% year-over-year); gross profit was CAD 7 million (46% margin).

  • Adjusted EBITDA loss for 2024 was CAD 16 million; Q4 2024 adjusted EBITDA loss was CAD 5.5 million.

  • Ended Q4 2024 with CAD 9.4 million in cash; subsequent financings raised over CAD 100 million for acquisitions and liquidity.

Outlook and guidance

  • Orion Health acquisition expected to close April 1, 2025, adding over CAD 100 million in annual revenue and driving EBITDA profitability.

  • 2025 guidance: AI/data science revenue expected to double, healthcare software to approach CAD 100 million, and clinical research to grow by 50%.

  • Gross margin expected to reach 50% on a blended basis post-Orion acquisition.

  • Focus on integrating Orion Health, executing disciplined M&A, and expanding Buy Canadian opportunities.

  • Cost optimization initiatives expected to yield at least CAD 3 million in annual savings.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more